Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApplied Nutrition PLC Regulatory News (APN)

Share Price Information for Applied Nutrition PLC (APN)

Share Price is delayed by 15 minutes
Get Live Data
309.50    0.00 (0.00%)
Bid:
309.50
Ask:
310.50
Spread: 1.00 (0.323%)
Market Cap: £773.75m
APN Live PriceLast checked at - London Stock Exchange

Intraday Applied Nutrition PLC Share Chart

Trading Update

9 Dec 2025 07:00

RNS Number : 7156K
Applied Nutrition PLC
09 December 2025
 

9 December 2025 

 Applied Nutrition plc

 

(the "Company")

Trading Update

 

Applied Nutrition plc (LSE: APN), a leading sports nutrition, health and wellness brand, today announces an update on trading for the current financial year ending 31 July 2026 ("FY26").

 

Further to the Company's positive trading outlook mentioned in the Final Results announcement on 10 November 2025, Applied Nutrition is pleased to announce that the strong momentum has continued and is also reflected in the current order book.

 

As a result the Company now expects that FY26 results are likely to exceed current market consensus estimates1 by approximately 10%.

 

The Company recognises the strength of trading and the upcoming peak trading period for Health, Fitness & Wellbeing, which will deliver a particularly strong H1.

 

 

Consensus market expectations for FY26 before today were revenue of £122.3m and adjusted EBITDA of £34.4m.

For further information please contact:

Applied Nutrition plc Thomas Ryder, Chief Executive OfficerSteven Granite, Chief Operating OfficerJoe Pollard, Chief Financial Officer

Via Alma

Alma Strategic Communications (Public Relations adviser to Applied Nutrition plc)

Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

+44 (0) 203 405 0205

appliednutrition@almastrategic.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Applied Nutrition is Joe Pollard, Chief Financial Officer.

Notes to editors

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world's most trusted and innovative brand in the market.

Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand - Applied Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group sells over 100 different products.

Applied Nutrition's growth is fuelled by a market-leading product portfolio, created and largely manufactured in-house at its Knowsley, Liverpool headquarters by a team of industry experts. This end-to-end capability allows the Group to innovate at speed, refresh and enhance existing products and introduce new offerings that anticipate and respond to the latest consumer trends.

Applied Nutrition largely operates a global business-to-business (B2B) model, which has facilitated a low risk, highly cost-effective go-to-market strategy and has enabled strong, profitable growth in the UK, Europe and other international geographies. The business model and strategy has enabled the Group to become a fast-growing, highly profitable and cash generative global supplier in the sports nutrition, health and wellness market.

For further information, please visit www.appliednutritionplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRBRVVUURAA
Date   Source Headline
15th Oct 20251:06 pmRNSHolding(s) in Company
14th Oct 202510:15 amRNSHolding(s) in Company
10th Oct 20259:03 amRNSHolding(s) in Company
9th Oct 20253:52 pmRNSHolding(s) in Company
8th Oct 202512:43 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSNotice of Results and Presentations
6th Oct 20259:36 amRNSHolding(s) in Company
3rd Oct 202511:52 amRNSHolding(s) in Company
2nd Oct 20251:33 pmRNSHolding(s) in Company
1st Oct 202512:51 pmRNSHolding(s) in Company
26th Sep 20254:25 pmRNSHolding(s) in Company
25th Sep 20259:35 amRNSHolding(s) in Company
18th Sep 20253:08 pmRNSHolding(s) in Company
17th Sep 20259:27 amRNSHolding(s) in Company
16th Sep 202511:10 amRNSHolding(s) in Company
11th Sep 20254:48 pmRNSHolding(s) in Company
9th Sep 20259:38 amRNSHolding(s) in Company
8th Sep 202511:19 amRNSHolding(s) in Company
8th Sep 20257:00 amRNSAppointment of Joint Broker
1st Sep 202512:44 pmRNSHolding(s) in Company
1st Sep 202512:36 pmRNSHolding(s) in Company
22nd Aug 20254:42 pmRNSHolding(s) in Company
21st Aug 20259:00 amRNSHolding(s) in Company
19th Aug 20257:00 amRNSFY25 Trading Update
18th Aug 20253:18 pmRNSHolding(s) in Company
14th Aug 20251:43 pmRNSHolding(s) in Company
13th Aug 20251:54 pmRNSHolding(s) in Company
12th Aug 20252:48 pmRNSHolding(s) in Company
11th Aug 202512:20 pmRNSHolding(s) in Company
7th Aug 20253:30 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
28th Jul 20253:59 pmRNSHolding(s) in Company
25th Jul 20255:08 pmRNSHolding(s) in Company
25th Jul 20255:07 pmRNSHolding(s) in Company
23rd Jul 202510:57 amRNSHolding(s) in Company
21st Jul 202511:57 amRNSHolding(s) in Company
17th Jul 20255:16 pmRNSHolding(s) in Company
16th Jul 20253:10 pmRNSHolding(s) in Company
14th Jul 20255:52 pmRNSHolding(s) in Company
14th Jul 202510:04 amRNSHolding(s) in Company
7th Jul 202512:42 pmRNSHolding(s) in Company
4th Jul 20252:31 pmRNSHolding(s) in Company
30th Jun 202510:35 amRNSHolding(s) in Company
19th Jun 20259:13 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
4th Jun 202510:50 amRNSHolding(s) in Company
2nd Jun 202511:31 amRNSDirector Declaration
2nd Jun 20257:00 amRNSDirectorate Change
8th Apr 202510:00 amRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.